146 related articles for article (PubMed ID: 22349684)
21. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
[TBL] [Abstract][Full Text] [Related]
22. The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.
Brettschneider J; Petzold A; Schottle D; Claus A; Riepe M; Tumani H
Dement Geriatr Cogn Disord; 2006; 21(5-6):291-5. PubMed ID: 16484807
[TBL] [Abstract][Full Text] [Related]
23. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
Aerts MB; Esselink RA; Claassen JA; Abdo WF; Bloem BR; Verbeek MM
J Alzheimers Dis; 2011; 27(2):377-84. PubMed ID: 21841257
[TBL] [Abstract][Full Text] [Related]
24. [A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index].
Molinuevo JL; Gispert JD; Pujol J; Rojas S; Lladó A; Balasa M; Antonell A; Sánchez-Valle R; Rami L
Rev Neurol; 2012 May; 54(9):513-22. PubMed ID: 22532214
[TBL] [Abstract][Full Text] [Related]
25. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
Hansson SF; Andréasson U; Wall M; Skoog I; Andreasen N; Wallin A; Zetterberg H; Blennow K
J Alzheimers Dis; 2009; 16(2):389-97. PubMed ID: 19221428
[TBL] [Abstract][Full Text] [Related]
26. Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD.
Lebedeva E; Stingl JC; Thal DR; Ghebremedhin E; Strauss J; Özer E; Bertram L; von Einem B; Tumani H; Otto M; Riepe MW; Högel J; Ludolph AC; von Arnim CA
Neurobiol Aging; 2012 Jan; 33(1):201.e9-18. PubMed ID: 20850903
[TBL] [Abstract][Full Text] [Related]
27. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
Maetzler W; Stoycheva V; Schmid B; Schulte C; Hauser AK; Brockmann K; Melms A; Gasser T; Berg D
J Alzheimers Dis; 2010; 22(3):933-8. PubMed ID: 20858953
[TBL] [Abstract][Full Text] [Related]
28. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias.
Blasko I; Lederer W; Oberbauer H; Walch T; Kemmler G; Hinterhuber H; Marksteiner J; Humpel C
Dement Geriatr Cogn Disord; 2006; 21(1):9-15. PubMed ID: 16244482
[TBL] [Abstract][Full Text] [Related]
29. Reduced CSF turnover and decreased ventricular Aβ42 levels are related.
Serot JM; Peltier J; Fichten A; Ledeme N; Bourgeois AM; Jouanny P; Toussaint P; Legars D; Godefroy O; Mazière JC
BMC Neurosci; 2011 May; 12():42. PubMed ID: 21569454
[TBL] [Abstract][Full Text] [Related]
30. Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory.
Dumurgier J; Paquet C; Benisty S; Kiffel C; Lidy C; Mouton-Liger F; Chabriat H; Laplanche JL; Hugon J
Neurobiol Dis; 2010 Nov; 40(2):456-9. PubMed ID: 20656030
[TBL] [Abstract][Full Text] [Related]
31. Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?
Schoonenboom NS; Mulder C; Van Kamp GJ; Mehta SP; Scheltens P; Blankenstein MA; Mehta PD
Ann Neurol; 2005 Jul; 58(1):139-42. PubMed ID: 15984010
[TBL] [Abstract][Full Text] [Related]
32. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
33. New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?
Fjell AM; Walhovd KB
Neuroscientist; 2011 Oct; 17(5):592-605. PubMed ID: 21518812
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
35. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
[TBL] [Abstract][Full Text] [Related]
36. Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer's disease.
Kant S; Stopa EG; Johanson CE; Baird A; Silverberg GD
Fluids Barriers CNS; 2018 Dec; 15(1):34. PubMed ID: 30541599
[TBL] [Abstract][Full Text] [Related]
37. Aminoterminally truncated and oxidized amyloid-β peptides in the cerebrospinal fluid of Alzheimer's disease patients.
Bibl M; Gallus M; Welge V; Esselmann H; Wiltfang J
J Alzheimers Dis; 2012; 29(4):809-16. PubMed ID: 22460324
[TBL] [Abstract][Full Text] [Related]
38. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.
Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Touchon J; Perret-Liaudet A; Lehmann S
Brain Res; 2010 Oct; 1357():175-83. PubMed ID: 20713025
[TBL] [Abstract][Full Text] [Related]
39. Importance of extracellular vesicle secretion at the blood-cerebrospinal fluid interface in the pathogenesis of Alzheimer's disease.
Vandendriessche C; Balusu S; Van Cauwenberghe C; Brkic M; Pauwels M; Plehiers N; Bruggeman A; Dujardin P; Van Imschoot G; Van Wonterghem E; Hendrix A; Baeke F; De Rycke R; Gevaert K; Vandenbroucke RE
Acta Neuropathol Commun; 2021 Aug; 9(1):143. PubMed ID: 34425919
[TBL] [Abstract][Full Text] [Related]
40. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid.
Crossgrove JS; Li GJ; Zheng W
Exp Biol Med (Maywood); 2005 Nov; 230(10):771-6. PubMed ID: 16246905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
